13G Filing: Perceptive Advisors and Ocera Therapeutics Inc. (OCRX)

Page 6 of 8 – SEC Filing

CUSIP
No. 67552A108
13G Page
6 of 8 Pages

 

Item
4.
Ownership.

 

Provide the following
information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

           
  (a) Amount
beneficially owned:

Perceptive
Advisors LLC and Joseph Edelman beneficially own 2,150,000
shares of Common Stock, 2,038,880 of which are held by Perceptive Life Sciences
Master Fund Ltd, a private investment fund (the “Fund”) to which Perceptive
Advisors LLC serves as the investment manager, and 111,120 of which are held in a trading
account (the “Account”) to which Perceptive Advisors LLC serves as the investment
manager. Mr. Edelman is the managing member of Perceptive Advisors LLC.

       
  (b) Percent
of class:

Perceptive
Advisors LLC’s and Joseph Edelman’s beneficial ownership of 9.11%, and Perceptive
Life Sciences Master Fund Ltd’s beneficial ownership of 8.63%, is based on the
sum of 23,600,242 shares of Common Stock as reflected on the Issuer’s 10-K filed
with the SEC on March 14, 2017.

       
  (c) Number
of shares as to which the person has:
Perceptive
Advisors LLC and Joseph Edelman
       
    (i) Sole
power to vote or to direct the vote:
0
    (ii) Shared
power to vote or to direct the vote:
2,150,000
    (iii) Sole
power to dispose or to direct the disposition of:
0
    (iv) Shared
power to dispose or to direct the disposition of:
2,150,000
         
    Perceptive
Life Sciences Master Fund Ltd:
 
         
    (i) Sole
power to vote or to direct the vote:  
0
    (ii) Shared
power to vote or to direct the vote:

2,038,880

    (iii) Sole
power to dispose or to direct the disposition of:
0
    (iv) Shared
power to dispose or to direct the disposition of:

2,038,880

             
Item 5. Ownership
of Five Percent or Less of a Class.

If this statement is being filed
to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent
of the class of securities, check the following: o.

Item
6.
Ownership of More Than Five
Percent on Behalf of Another Person.

The Fund and the Account described
in Item 4 have the right to receive or the power to direct the receipt of dividends from, or the proceeds from, the sale of the
securities held in its account. Filing of this statement by the Reporting Persons shall not be deemed an admission that they beneficially
own the securities reported herein. The Reporting Persons expressly disclaim beneficial ownership of all securities reported herein.

Item 7. Identification
and Classification of the Subsidiary which Acquired the Security Being Reported on by
the Parent Holding Company or Control Person.

 

Not applicable.

Follow Ocera Therapeutics Inc. (NASDAQ:OCRX)